These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38087420)

  • 21. Leg ulceration with associated thrombocytosis: healing of ulceration associated with treatment of the raised platelet count.
    Wirth K; Schoepf E; Mertelsmann R; Lindemann A
    Br J Dermatol; 1998 Mar; 138(3):533-5. PubMed ID: 9580816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxyurea-induced leg ulcers treated with a protease-modulating matrix.
    Romanelli M; Dini V; Romanelli P
    Arch Dermatol; 2007 Oct; 143(10):1310-3. PubMed ID: 17938346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hydroxyurea-induced leg ulcers in patients with chronic myeloproliferative disorders].
    Olesen LH; Pedersen BB
    Ugeskr Laeger; 2001 Dec; 163(49):6908-11. PubMed ID: 11766504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxyurea-induced genital ulcers and erosions: Two case reports.
    Blum AE; Tsiaras WG; Kemp JM
    J Tissue Viability; 2021 Aug; 30(3):462-464. PubMed ID: 34147315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal melanonychia associated with hydroxyurea therapy in a patient with essential thrombocytosis.
    Cohen AD; Hallel-Halevy D; Hatskelzon L; Peretz E; Halevy S
    J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):137-9. PubMed ID: 10568495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Essential thrombocytosis--a criteria diagnosis. Important to differentiate from reactive/secondary thrombocytosis].
    Andreasson B; Johansson P; Samuelsson J
    Lakartidningen; 2009 Jan 14-20; 106(3):110-3. PubMed ID: 19248460
    [No Abstract]   [Full Text] [Related]  

  • 27. Implications of the consensus definition of clinical resistance and intolerance to hydroxyurea for clinical practice.
    Reilly JT
    Eur J Haematol Suppl; 2007 Oct; (68):32-4. PubMed ID: 17727564
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hyperalgesic malleolar ulcer: recovery on the withdrawal of hydroxyurea].
    Liebschutz S; Quéré I; Lukasik E; Dereure O; Rondes J; Janbon C
    Rev Med Interne; 1998 May; 19(5):360-1. PubMed ID: 9775174
    [No Abstract]   [Full Text] [Related]  

  • 29. Vasculitic Leg Ulcer Revealing an Essential Thrombocythemia.
    Lopes S; Esteves M; Baudrier T; Pardal J; Azevedo F
    Skinmed; 2019; 17(3):204-205. PubMed ID: 31496479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombocytosis and thrombocythemia.
    Schafer AI
    Blood Rev; 2001 Dec; 15(4):159-66. PubMed ID: 11792116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leg ulcers in patients with myeloproliferative disorders: disease- or treatment-related?
    Bader U; Banyai M; Böni R; Burg G; Hafner J
    Dermatology; 2000; 200(1):45-8. PubMed ID: 10681614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The management of malignant lower limb ulcers: clinical considerations.
    Ghaly P; Kim YD; Iliopoulos J; Ahmad M
    Br J Nurs; 2020 Aug; 29(15):S34-S40. PubMed ID: 32790548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucocutaneous lesions and nail pigmentation in a patient with essential thrombocytosis.
    Calleja Algarra A; Miguel RA; Tous Romero F; Maroñas Jiménez L
    Aust Fam Physician; 2017; 46(4):222-224. PubMed ID: 28376576
    [No Abstract]   [Full Text] [Related]  

  • 34. Persistent thrombocytosis in elderly patients with rare hyposplenias that mimic essential thrombocythemia.
    Imashuku S; Kudo N; Kubo K; Takahashi N; Tohyama K
    Int J Hematol; 2012 Jun; 95(6):702-5. PubMed ID: 22527856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxyurea-induced foot ulcer in a case of essential thrombocythaemia.
    Tsuchiya S; Ichioka S; Sekiya N
    J Wound Care; 2010 Aug; 19(8):361-4. PubMed ID: 20852510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxyurea and fetal hemoglobin effect on leg ulcers in patients with sickle cell disease.
    Tolu SS; Crouch A; Choi J; Gao Q; Reyes-Gil M; Ogu UO; Vinces G; Minniti CP
    Ann Hematol; 2022 Mar; 101(3):541-548. PubMed ID: 35039901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of hydroxyurea-associated chronic leg ulcers associated with squamous cell carcinoma.
    Antar A; Ishak RS; Otrock ZK; El-Majzoub N; Ghosn S; Mahfouz R; Taher AT
    Hematol Oncol Stem Cell Ther; 2014 Dec; 7(4):166-9. PubMed ID: 25467031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repairing of recurrent leg ulcer induced by hydroxyurea with posterior tibial artery perforator propeller flap: Case report.
    Wan ZD; Li WZ
    Int J Surg Case Rep; 2024 Jan; 114():109049. PubMed ID: 38029574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Leg ulcers in essential thrombocythemia].
    Kaufmann R; Landes E
    Hautarzt; 1984 May; 35(5):259-62. PubMed ID: 6746292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute myeloid leukemia and myelofibrosis: Simultaneous transformation of essential thrombocythemia during treatment with hydroxyurea.
    Nalluru SS; Efe O; Chen Y; Trivedi N
    J Cancer Res Ther; 2022; 18(4):1180-1182. PubMed ID: 36149183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.